Neurocrine Biosciences, Inc. - Common Stock — Quarterly Balance Sheet (NASDAQ:NBIX) | MetaTrader

Open full chart

News

Can Neurocrine (NBIX) Run Higher on Rising Earnings Estimates?

Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus

GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer

CG Oncology Stock Gains 12% in Three Months: What's Driving It?

3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX)

United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Three Enticing Clues Put This Broadcom Partner, Nvidia Rival In Focus

Neurocrine (NBIX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists

VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout

Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles